logo-loader
viewTHC Global Group Ltd

Full interview: THC Global receives final licences and will complete product validation by end of year

THC Global Group Ltd (ASX:THC) chief executive officer Ken Charteris updates Proactive on receiving the final licences required for Australian production and distribution of narcotic medicines, including medicinal cannabis, for the recently opened Southport and Bundaberg manufacturing facilities in Queensland.

The company will also complete product validation by the end of 2019 and expects to be supplying medicinal cannabis to Australian patients early in 2020.

In addition, the CEO updated the market about an increased presence for THC Global in New Zealand.

Quick facts: THC Global Group Ltd

Price: 0.39 AUD

ASX:THC
Market: ASX
Market Cap: $53.3 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

THC Global starts manufacturing at Southport facility after green light from...

THC Global Group Ltd’s (ASX:THC) group chief executive officer Ken Charteris updates Proactive after the company received a key medicinal cannabis manufacture permit for its Southport facility from the Australia regulator, allowing production to start immediately. Charteris says this is...

1 week, 3 days ago

2 min read